Across TCGA pan-cancer cohorts, RNA5SP409 RNA is linked to patient survival in 1 of 34 cancer types, making it the most broadly survival-associated RNA5SP409 data layer.
The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RNA5SP409 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNA5SP409 expression acts as an unfavorable survival marker.
KIRC are the cancer types where RNA5SP409 RNA most reproducibly stratifies survival.